Life Spine has received clearance from the US Food and Drug Administration (FDA) to market the ProLift micro Expandable Spacer System.
ProLift micro is designed to support micro invasive procedures ranging from endoscopic transforaminal lumbar interbody fusion to transforaminal and posterior lumbar interbody fusion using minimally invasive spine surgery.
ProLift micro features an 8mm width, self-locking expansion at any height (8mm to 16mm) to suit the patient’s individual pathology and anatomical conditions. In addition, ProLift micro is available in a range of sizes and footprints.
Rich Mueller, chief operating officer for Life Spine, said: “ProLift micro is designed for a fully percutaneous fusion via an endoscopic approach. The procedure, which is being developed for next year, consists of fully integrated augmented reality (AR) and 3D imaging. The AR vision system allows the surgeon to view live endoscopic 3D video, interactive product images and pre-op/real time radiographs.”
ProLift micro is Life Spine’s 14th expandable interbody device.
